We are live on ! Find out more
ZSPH

ZS PHARMA INC COMS TK (DE)
ZSPH

Delisted

ZSPH was delisted on the 16th of December, 2015.

92 hedge funds and large institutions have $711M invested in ZS PHARMA INC COMS TK (DE) in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 14

108% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 13

37% more capital invested

Capital invested by funds: $519M → $711M (+$193M)

18% more funds holding

Funds holding: 7892 (+14)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
92
Holders Change
+14
Holders Change %
+17.95%
% of All Funds
2.45%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
27
Increased
41
Reduced
14
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$4.1M +$14.2K +310 +0.3%
BIT
27
BlackRock Institutional Trust
California
$3.89M +$1.21M +26,376 +40%
State Street
28
State Street
Massachusetts
$3.81M +$508K +11,112 +14%
Lazard Asset Management
29
Lazard Asset Management
New York
$3.75M +$4.08M +89,175 New
Millennium Management
30
Millennium Management
New York
$3.72M +$3.63M +79,296 +864%
Citadel Advisors
31
Citadel Advisors
Florida
$3.63M +$3.71M +81,126 +1,615%
NIP
32
Nicholas Investment Partners
California
$3.57M +$1.53M +33,378 +65%
LCM
33
Laurion Capital Management
New York
$3.44M +$3.73M +81,634 New
AA
34
AQR Arbitrage
Connecticut
$3.16M +$3.43M +75,000 New
OM
35
Opaleye Management
Massachusetts
$3.16M +$3.43M +75,000 New
RI
36
RTW Investments
New York
$3M -$13.9M -303,506 -81%
Northern Trust
37
Northern Trust
Illinois
$2.97M +$106K +2,323 +3%
EI
38
EAM Investors
California
$2.96M -$581K -12,716 -15%
MCM
39
Mazama Capital Management
Oregon
$2.7M +$1.42M +30,946 +93%
MIM
40
Monashee Investment Management
Massachusetts
$2.52M +$2.74M +60,000 New
JP Morgan Chase
41
JP Morgan Chase
New York
$2.47M -$818K -17,883 -23%
Geode Capital Management
42
Geode Capital Management
Massachusetts
$1.7M +$66.6K +1,456 +4%
DCM
43
DAFNA Capital Management
California
$1.65M +$1.79M +39,100 New
DCM
44
Driehaus Capital Management
Illinois
$1.6M +$1.74M +38,021 New
TD Asset Management
45
TD Asset Management
Ontario, Canada
$1.57M +$901K +19,700 +112%
UBS Group
46
UBS Group
Switzerland
$1.55M -$661K -14,448 -28%
Wells Fargo
47
Wells Fargo
California
$1.54M +$1.64M +35,905 +6,201%
PAMU
48
Pictet Asset Management (UK)
United Kingdom
$1.44M +$1.73M +37,800 New
CS
49
Credit Suisse
Switzerland
$1.38M +$673K +14,708 +82%
QSS
50
Quantitative Systematic Strategies
Florida
$1.34M +$1.44M +31,593 New

ZSPH Hedge Fund Activity: Q1 2015 in Review

92 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q1 2015, worth a combined $711M — up 37% from $519M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ZSPH positions and 13 closed out — a net gain of 14 holders — while 41 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $20.5M sold.

  • 92 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q1 2015, up from 78 in Q4 2014.
  • Funds reported $711M of ZS PHARMA INC COMS TK (DE) stock for Q1 2015, up 37% quarter-over-quarter.
  • 27 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q1 2015 and 13 closed out, a net change of +14 holders.
  • The largest ZS PHARMA INC COMS TK (DE) buyer in Q1 2015 was Fidelity Investments, an estimated $36M added.
  • The largest ZS PHARMA INC COMS TK (DE) seller in Q1 2015 was Adage Capital Partners, an estimated $20.5M sold.

Based on aggregated 13F filings for Q1 2015.